KK
DNTH icon

KLP Kapitalforvaltning’s Dianthus Therapeutics DNTH Stock Holding History

KLP Kapitalforvaltning’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Hold
8,900
– – ﹤0.01% 1212
2026
Q1 		$747K Buy
8,900
+5,500
+162% +$319K ﹤0.01% 1193
2025
Q4 		$140K Buy
+3,400
New +$132K ﹤0.01% 1968
2025
Q1 		– Sell
-1,500
Closed -$32.7K – 2265
2024
Q4 		$32.7K Buy
+1,500
New +$38.6K ﹤0.01% 2274

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

KLP Kapitalforvaltning's DNTH Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Dianthus Therapeutics (DNTH) position steady in Q2 2026 at 8,900 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

KLP Kapitalforvaltning first reported a position in DNTH in Q4 2024 and has held it in 4 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • KLP Kapitalforvaltning held 8,900 shares of Dianthus Therapeutics worth $868K as of Q2 2026.
  • KLP Kapitalforvaltning left its Dianthus Therapeutics share count unchanged in Q2 2026.
  • Dianthus Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1212 holding.
  • KLP Kapitalforvaltning first reported a position in Dianthus Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.